Scholars Central

Conference abstractPublished 19 May 2022

The role of Immunohistochemistry for evaluation of Muscle Biopsies

Authors: Caroline A. Sewry

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Evaluation of a muscle biopsies is an important part of the diagnostic pathway of a neuromuscular disorder, even though next generation sequencing is now more widely used. Muscle biopsy can contribute to the selection of appropriate gene panels, to the assessment of the pathogenicity of gene variants and identify specific pathological features when next generation sequencing has produced negative results. Immunohistochemistry is an essential tool for the assessment of a muscle biopsy, but the data must always be correlated with the clinical, biochemical, electrophysiological, imaging, histological and histochemical results. The localisation of antibodies by immunohistochemistry can identify specific protein abnormalities resulting from a primary defect in a gene, for example the absence of a particular sarcolemmal protein can often identify the form of muscular dystrophy. Studies of secondary abnormalities also have a role, such as the over-expression of a protein in response to a primary defect in a gene. In acquired, non-inherited neuromuscular disorders immunohistochemistry can identify several informative abnormalities that aid diagnosis, direct appropriate therapy and aid differential diagnosis. Immunohistochemical studies of antibodies to myosin heavy chain isoforms are now recognised as an important tool for the assessment of fibre types in both inherited and acquired muscle disorders, for assessing maturity of fibres and for determining if a muscle sample is normal or abnormal. Recent Publications: 1. Importance of immunohistochemical evaluation of developmentally regulated myosin heavy chains in human muscle biopsies. Sewry CA, Feng L, Chambers D, Matthews E, Phadke R.Neuromuscul Disord. 2021 May;31(5):371-384.DOI: 10.1016/j.nmd.2021.02.007. 2. Nemaline myopathies: a current view. Sewry CA, Laitila JM, Wallgren-Pettersson C.J Muscle Res Cell Motil. 2019 Jun;40(2):111-126. doi: 10.1007/s10974-019-09519-9. Epub 2019 Jun 21.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Neurology and Clinical Neuroscience.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Neurology and Clinical Neuroscience
  • SubjectNeuroscience & Neurology
  • BylineArticles whose byline prints “Caroline A. Sewry”